Beller F, Theiss W
Department of Obstetrics and Gynecology, Medical College, University of Iowa City.
Zentralbl Gynakol. 1994;116(8):441-8.
Survey about oral contraceptives and postmenopausal hormonal replacement therapy and the effects on coagulation system. The question to withdraw oral contraceptives 4 weeks before a gynecological operation cannot be answered sufficiently. The pros and cons have been discussed. Thromboembolic disorders in the history of a patient are contraindications for oral contraceptives. It can be anticipated, that this rule will be changed in future. There are no scientific hints, which could bring a phlebitis or varicosis in connection etiologically with a thromboembolic disorder during oral contraceptives.
关于口服避孕药和绝经后激素替代疗法及其对凝血系统影响的调查。关于妇科手术前4周停用口服避孕药的问题无法得到充分解答。已经讨论了利弊。患者有血栓栓塞性疾病史是口服避孕药的禁忌证。可以预见，这一规则未来将会改变。没有科学依据表明口服避孕药期间的血栓栓塞性疾病在病因上与静脉炎或静脉曲张有关。
